TWIST1 and neoplasm: The current study uncovered a function of Twist1 in tumor–stromal cell communication, demonstrated that Twist1 could be a useful prognostic marker, and indicated that high Twist1 expression correlated with poor prognosis in ESCC, making Twist1 a solid candidate as a potent therapeutic target for ESCC.